Generation Bio Co (GBIO) support and resistance · rev $19.9M
Generation Bio Co (GBIO) is a biotechnology company listed on US.
This page maps Generation Bio Co (GBIO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported GBIO revenue for 2024-12-31 was $19.9M. Net income was -$131.7M. Revenue was up 236.9% from 2023-12-31 to 2024-12-31. GBIO currently screens at market cap $25.4M.
GBIO currently screens at market cap $25.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new GBIO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the GBIO quote page for the session range and the stock page for the full model.
Not investment advice.